BBNX: Beta Bionics, Inc.
Performance
BBNX -35.55%
Watchlist
Select an item
Summary
BBNX at a glance
BBNX returned -35.55% over the past year. Its worst drop in that year was -72.30%, smaller than 4% of stocks on Redstone, and its Sharpe ratio of -0.12 beats 22% of stocks on Redstone. It pays no dividends.
Current Drawdown
-47.01%
Rolling Volatility
100.82%
Actions
Metrics
Risk Indicators
Alpha-24.87%
Beta1.48x
Sharpe-0.12
Sortino-0.17
Omega0.98
Calmar-0.49
Martin-0.21
Profile
About BBNX
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease.
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $922M
- Listed
- Jan 2025
- Employees
- 423
- Headquarters
- Irvine, CA
- Website
- betabionics.com
Comparisons